4//SEC Filing
Collins Helen Louise 4
Accession 0001209191-23-023676
CIK 0001672619other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:32 PM ET
Size
5.5 KB
Accession
0001209191-23-023676
Insider Transaction Report
Form 4
Collins Helen Louise
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2023-04-04+206,000→ 206,000 totalExercise: $22.75Exp: 2033-04-04→ Common Stock (206,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option will vest on February 23, 2024 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001701247
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 8:32 PM ET
- Size
- 5.5 KB